Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Harm Reduction Policy topic
No spam. Unsubscribe anytime.
Committee hears bill to define and authorize harm‑reduction activities, add law‑enforcement consultation and a statewide doorway program
Summary
House Bill 73 would create statutory definitions and guardrails for harm reduction (recast as reduction of societal and individual harm), add law‑enforcement representation and consultation requirements, and codify the Doorways program and other substance‑use access points.
Representative David Nagel, a physician and the bill’s sponsor in the House, described House Bill 73 as a framework to give statutory definition and legislative oversight to policies the governor’s commission and federal agencies call harm reduction. Nagel said the bill was written to create common terminology so the state can align with federal grant programs and ensure consistent implementation across agencies.
The bill replaces the term “harm reduction” in most places with “reduction of societal and individual harm,” language Representative Jess Edwards and others helped craft to balance individual life‑saving measures with community impacts. Senator David Waters, a member of the governor’s commission, told the committee the change was intended to strike that balance and to ensure local municipal officials and law enforcement are included in planning and operations for programs such as syringe service programs.
Senator Waters and other proponents described three core changes: establishing the governor’s commission’s authority over harm‑reduction strategy, adding a chiefs‑of‑police representative to the commission, and requiring consultation with local law enforcement where syringe service and other harm‑reduction programs are established. The bill also places the Doorways program into statute as a statewide access point for overdose response and linkage to services.
Chief David Suckling of the Alexandria Police Department testified in support, describing local law‑enforcement efforts to distribute naloxone and to partner with recovery programs. He said his department has distributed roughly 3,000 doses of naloxone and adopted recovery‑oriented practices.
Committee members asked about data on program impacts—Senator Long asked whether data were available on reductions in deaths, needle counts, and program reach. Supporters said the governor’s commission and HHS collect reports and data on naloxone distribution, syringe service program activity and Doorways, and that gaps remain in attributing specific outcomes to individual programs. Proponents pointed to reductions in fatal overdoses in recent reporting and to routine reporting to the commission and HHS as evidence the state can track program activity.
After discussion, the committee moved and approved the bill by voice consent. Several lawmakers emphasized the statutory definition and the requirement for local consultation were intended to address concerns that prompted debate in prior sessions.
